ACAD
37.91
+1.53
+4.21%
AEMD
7.15
+0.23
+3.32%
APRI
1.23
-0.04
-3.15%
ARNA
2.65
-0.07
-2.57%
ATEC
0.57
-0.01
-1.64%
CNAT
3.68
+0.15
+4.25%
CRXM
0.39
0.00
0.00%
CYTX
0.299
-0.027
-8.2183%
DXCM
93.74
+2.21
+2.41%
GNMK
9.43
-0.03
-0.32%
HALO
18.04
+0.58
+3.32%
ILMN
201.94
+6.24
+3.19%
INNV
0.145
+0.021
+16.653%
INO
6.98
+0.18
+2.65%
ISCO
3.65
0.00
0.00%
ISIS
51.56
+2.54
+5.18%
LGND
94.25
+3.36
+3.70%
LPTN
0.21
-0.002
-0.7558%
MBVX
1.69
+0.17
+11.55%
MEIP
1.69
+0.03
+1.81%
MNOV
2.97
+0.12
+4.21%
MRTX
25.49
+0.57
+2.29%
MSTX
0.452
+0.012
+2.7500%
NBIX
46.26
+2.29
+5.21%
NUVA
52.75
+1.03
+1.99%
ONCS
5.175
+0.055
+1.074%
ONVO
2.5
+0.19
+8.23%
OREX
2.76
+0.06
+2.22%
OTIC
23.38
+0.19
+0.82%
QDEL
20.7
+0.13
+0.63%
RCPT
231.96
-0.03
-0.01%
RGLS
7.48
+0.28
+3.89%
RMD
51.65
-0.16
-0.31%
SCIE
0.014
0.00
0.00%
SPHS
0.86
0.00
0.00%
SRNE
13.32
+0.85
+6.82%
TROV
5.78
+0.42
+7.84%
VICL
0.56
+0.00
+0.0357%
VOLC
18
0.00
0.00%
ZGNX
17.06
+0.51
+3.11%
ACAD
37.91
+1.53
+4.21%
AEMD
7.15
+0.23
+3.32%
APRI
1.23
-0.04
-3.15%
ARNA
2.65
-0.07
-2.57%
ATEC
0.57
-0.01
-1.64%
CNAT
3.68
+0.15
+4.25%
CRXM
0.39
0.00
0.00%
CYTX
0.299
-0.027
-8.2183%
DXCM
93.74
+2.21
+2.41%
GNMK
9.43
-0.03
-0.32%
HALO
18.04
+0.58
+3.32%
ILMN
201.94
+6.24
+3.19%
INNV
0.145
+0.021
+16.653%
INO
6.98
+0.18
+2.65%
ISCO
3.65
0.00
0.00%
ISIS
51.56
+2.54
+5.18%
LGND
94.25
+3.36
+3.70%
LPTN
0.21
-0.002
-0.7558%
MBVX
1.69
+0.17
+11.55%
MEIP
1.69
+0.03
+1.81%
MNOV
2.97
+0.12
+4.21%
MRTX
25.49
+0.57
+2.29%
MSTX
0.452
+0.012
+2.7500%
NBIX
46.26
+2.29
+5.21%
NUVA
52.75
+1.03
+1.99%
ONCS
5.175
+0.055
+1.074%
ONVO
2.5
+0.19
+8.23%
OREX
2.76
+0.06
+2.22%
OTIC
23.38
+0.19
+0.82%
QDEL
20.7
+0.13
+0.63%
RCPT
231.96
-0.03
-0.01%
RGLS
7.48
+0.28
+3.89%
RMD
51.65
-0.16
-0.31%
SCIE
0.014
0.00
0.00%
SPHS
0.86
0.00
0.00%
SRNE
13.32
+0.85
+6.82%
TROV
5.78
+0.42
+7.84%
VICL
0.56
+0.00
+0.0357%
VOLC
18
0.00
0.00%
ZGNX
17.06
+0.51
+3.11%
Home » Archive by Category

Xconomy

In Move That Spells Relief, Zogenix Sells Painkiller to Pernix

March 10, 2015 – 6:50 pm

Zohydro was supposed to be a new kind of painkiller, but it gave Zogenix CEO Roger Hawley a headache that lasted more than a year. Now perhaps he can rest a little easier. After introducing Zohydro…

[[Click headline to continue reading.]]

Companion Diagnostic Specialist AltheaDx Withdraws IPO

March 10, 2015 – 8:20 am

San Diego’s AltheaDx, which offers a series of molecular diagnostic tests that enable doctors to identify the optimal drugs for treating patients, yesterday withdrew its plans for an initial public…

[[Click headline to continue reading.]]

NIH Director Hails “Stunning Case” as Example of Genomic Revolution

March 6, 2015 – 7:37 am

A pregnant mom who got a non-invasive prenatal test because she knew at age 40 that her baby was a higher risk for Down syndrome has become a case study in the potential power of precision medicine….

[[Click headline to continue reading.]]

NIH Director Hails “Stunning Case” as Example of Genomic Revolution

March 6, 2015 – 7:37 am

A pregnant mom who got a non-invasive prenatal test because she knew at age 40 that her baby was a higher risk for Down syndrome has become a case study in the potential power of precision medicine….

[[Click headline to continue reading.]]

West Coast Biotech Roundup: Pharmacyclics, Gates, Ikaria & More

March 5, 2015 – 3:01 pm

[Corrected 3/9/15, 11:46 pm. See below.] What a week for West Coast news, topped off by AbbVie’s surprise $21 billion grab of Pharmacyclics. It’s the ninth-largest biopharma acquisition…

[[Click headline to continue reading.]]

West Coast Biotech Roundup: Pharmacyclics, Gates, Ikaria & More

March 5, 2015 – 3:01 pm

[Corrected 3/9/15, 11:46 pm. See below.] What a week for West Coast news, topped off by AbbVie’s surprise $21 billion grab of Pharmacyclics. It’s the ninth-largest biopharma acquisition…

[[Click headline to continue reading.]]

With Narrowed Focus, Elcelyx Prepares for Diabetes Drug Trial

March 5, 2015 – 6:30 am

For San Diego’s Elcelyx Therapeutics, 2014 may someday be remembered as “the year of heavy lifting.” Since the fall of 2013, when Elcelyx spun out NaZura BioHealth as a sister company with the same…

[[Click headline to continue reading.]]

With Narrowed Focus, Elcelyx Prepares for Diabetes Drug Trial

March 5, 2015 – 6:30 am

For San Diego’s Elcelyx Therapeutics, 2014 may someday be remembered as “the year of heavy lifting.” Since the fall of 2013, when Elcelyx spun out NaZura BioHealth as a sister company with the same…

[[Click headline to continue reading.]]

“Voice for Everyone”—Life-Sci Women Talk Venture, Pharma Gender Gap

March 4, 2015 – 3:55 pm

By the numbers, the rare-disease drug developer Raptor Pharmaceutical (NASDAQ: RPTP) recently upped its chances of better market performance. That’s because biopharma veteran Julie Anne Smith…

[[Click headline to continue reading.]]

“Voice for Everyone”—Life-Sci Women Talk Venture, Pharma Gender Gap

March 4, 2015 – 3:55 pm

By the numbers, the rare-disease drug developer Raptor Pharmaceutical (NASDAQ: RPTP) recently upped its chances of better market performance. That’s because biopharma veteran Julie Anne Smith…

[[Click headline to continue reading.]]